Brown; S. David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brown; S. David.The latest application filed is for "(alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases".

Company Profile

5.16.19

Brown; S. David - San Carlos CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases Grant 11,400,097 - Brown , et al. August 2, 2	2022-08-02
(alpha-substituted Aralkylamino And Heteroarylalkylamino) Pyrimidinyl And 1,3,5-triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, And Their Use In Treating Proliferative Diseases App 20200316080 - BROWN; S. David ; et al.	2020-10-08
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases Grant 10,603,324 - Brown , et al.	2020-03-31
(alpha-substituted Aralkylamino And Heteroarylalkylamino) Pyrimidinyl And 1,3,5-triazinyl Benzimidazoles, Pharmaceutical Composi App 20200009151 - BROWN; S. David ; et al.	2020-01-09
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases Grant 10,335,415 - Brown , et al.	2019-07-02
(alpha-substituted Aralkylamino And Heteroarylalkylamino) Pyrimidinyl And 1,3,5-triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, And Their Use In Treating Proliferative Diseases App 20190083506 - BROWN; S. David ; et al.	2019-03-21
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases Grant 10,064,868 - Brown , et al. September 4, 2	2018-09-04
(alpha-substituted Aralkylamino And Heteroarylalkylamino) Pyrimidinyl And 1,3,5-triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, And Their Use In Treating Proliferative Diseases App 20150265625 - BROWN; S. David ; et al.	2015-09-24
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases Grant 9,056,852 - Brown , et al. June 16, 2	2015-06-16
Phosphatidylinositol 3-kinase inhibitors and methods of their use Grant 8,889,664 - Bajjalieh , et al. November 18, 2	2014-11-18
(alpha-substituted Cycloalkylamino And Heterocyclylamino) Pyrimidinyl And 1,3,5-triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, And Their Use In Treating Proliferative Diseases App 20140088102 - Brown; S. David ; et al.	2014-03-27
(fused Ring Arylamino And Heterocyclylamino) Pyrimidinyl And 1,3,5-triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, And Their Use In Treating Proliferative Diseases App 20140088103 - Brown; S. David ; et al.	2014-03-27
JAK1 Inhibitors App 20130165440 - Anand; Neel Kumar ; et al.	2013-06-27
4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of use Grant 8,440,663 - Mann , et al. May 14, 2	2013-05-14
(alpha-substituted Aralkylamino And Heteroarylalkylamino) Pyrimidinyl And 1,3,5-triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, And Their Use In Treating Proliferative Diseases App 20120252802 - Brown; S. David ; et al.	2012-10-04
6-phenylpyrimidinones as PIM modulators Grant 8,242,129 - Tsuhako , et al. August 14, 2	2012-08-14
Pyridopyrimidinone inhibitors of PIM-1 and/or PIM-3 Grant 8,053,454 - Kearney , et al. November 8, 2	2011-11-08
Tie-2 modulators and methods of use Grant 8,013,156 - Canne Bannen , et al. September 6, 2	2011-09-06
Phosphatidylinositol 3-Kinase Inhibitors And Methods Of Their Use App 20110207712 - Bajjalieh; William ; et al.	2011-08-25
Phosphatidylinositol 3-kinase inhibitors and methods of their use Grant 7,989,622 - Bajjalieh , et al. August 2, 2	2011-08-02
Human adam-10 inhibitors Grant 7,951,972 - Brown , et al. May 31, 2	2011-05-31
6-Phenylpyrimidinones as PIM Modulators App 20100135954 - Tsuhako; Amy L. ; et al.	2010-06-03
Phosphatidylinositol 3-Kinase Inhibitors and Methods of Their Use App 20100087440 - Bajjalieh; William ; et al.	2010-04-08
4-Aryl-2-Amino-Pyrimidnes or 4-Aryl-2-Aminoalkyl-Pyrimidines as Jak-2 Modulators and Methods of Use App 20090298830 - Mann; Grace ; et al.	2009-12-03
Benzofuropyrimidinones App 20090247559 - Brown; S. David ; et al.	2009-10-01
Human adam-10 inhibitors App 20090143386 - Brown; S. David ; et al.	2009-06-04
Human ADAM-10 inhibitors Grant 7,498,358 - Brown , et al. March 3, 2	2009-03-03
Pyridopyrimidinone Inhibitors of PIM-1 and/or PIM-3 App 20090042918 - Kearney; Patrick ; et al.	2009-02-12
Tie-2 Modulators and Methods of Use App 20070275952 - Bannen; Lynne Canne ; et al.	2007-11-29
Human adam-10 inhibitors App 20050227973 - Brown, S. David ; et al.	2005-10-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.